Literature DB >> 24362500

Semiautomated volumetric response evaluation as an imaging biomarker in superior sulcus tumors.

C G Vos1, M Dahele, J R van Sörnsen de Koste, S Senan, I Bahce, M A Paul, E Thunnissen, E F Smit, K J Hartemink.   

Abstract

BACKGROUND: Volumetric response to therapy has been suggested as a biomarker for patient-centered outcomes. The primary aim of this pilot study was to investigate whether the volumetric response to induction chemoradiotherapy was associated with pathological complete response (pCR) or survival in patients with superior sulcus tumors managed with trimodality therapy. The secondary aim was to evaluate a semiautomated method for serial volume assessment.
METHODS: In this retrospective study, treatment outcomes were obtained from a departmental database. The tumor was delineated on the computed tomography (CT) scan used for radiotherapy planning, which was typically performed during the first cycle of chemotherapy. These contours were transferred to the post-chemoradiotherapy diagnostic CT scan using deformable image registration (DIR) with/without manual editing.
RESULTS: CT scans from 30 eligible patients were analyzed. Median follow-up was 51 months. Neither absolute nor relative reduction in tumor volume following chemoradiotherapy correlated with pCR or 2-year survival. The tumor volumes determined by DIR alone and DIR + manual editing correlated to a high degree (R(2) = 0.99, P < 0.01).
CONCLUSION: Volumetric response to induction chemoradiotherapy was not correlated with pCR or survival in patients with superior sulcus tumors managed with trimodality therapy. DIR-based contour propagation merits further evaluation as a tool for serial volumetric assessment.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24362500     DOI: 10.1007/s00066-013-0482-3

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  25 in total

Review 1.  Change in lung tumor volume as a biomarker of treatment response: a critical review of the evidence.

Authors:  P D Mozley; L H Schwartz; C Bendtsen; B Zhao; N Petrick; A J Buckler
Journal:  Ann Oncol       Date:  2010-03-23       Impact factor: 32.976

2.  Interobserver variability of clinical target volume delineation in supra-diaphragmatic Hodgkin's disease: a multi-institutional experience.

Authors:  Domenico Genovesi; Giampiero Ausili Cèfaro; Annamaria Vinciguerra; Antonietta Augurio; Monica Di Tommaso; Rita Marchese; Umberto Ricardi; Andrea Riccardo Filippi; Theodore Girinsky; Katiuscia Di Biagio; Maurizio Belfiglio; Enza Barbieri; Vincenzo Valentini
Journal:  Strahlenther Onkol       Date:  2011-05-16       Impact factor: 3.621

3.  Metabolic tumor volume is an independent prognostic factor in patients treated definitively for non-small-cell lung cancer.

Authors:  Percy Lee; Jose G Bazan; Philip W Lavori; Dilani K Weerasuriya; Andrew Quon; Quynh-Thu Le; Heather A Wakelee; Edward E Graves; Billy W Loo
Journal:  Clin Lung Cancer       Date:  2011-06-24       Impact factor: 4.785

4.  Response to treatment series: part 2, tumor response assessment--using new and conventional criteria.

Authors:  Vahid Yaghmai; Frank H Miller; Pedram Rezai; Al B Benson; Riad Salem
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

5.  Tumor volume reduction rate after preoperative chemoradiotherapy as a prognostic factor in locally advanced rectal cancer.

Authors:  Seung-Gu Yeo; Dae Yong Kim; Ji Won Park; Jae Hwan Oh; Sun Young Kim; Hee Jin Chang; Tae Hyun Kim; Byung Chang Kim; Dae Kyung Sohn; Min Ju Kim
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-24       Impact factor: 7.038

6.  The evaluation of a deformable image registration segmentation technique for semi-automating internal target volume (ITV) production from 4DCT images of lung stereotactic body radiotherapy (SBRT) patients.

Authors:  Richard Speight; Jonathan Sykes; Rebecca Lindsay; Kevin Franks; David Thwaites
Journal:  Radiother Oncol       Date:  2011-01-21       Impact factor: 6.280

7.  Daily megavoltage computed tomography in lung cancer radiotherapy: correlation between volumetric changes and local outcome.

Authors:  Samuel Bral; Mark De Ridder; Michaël Duchateau; Thierry Gevaert; Benedikt Engels; Denis Schallier; Guy Storme
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-07-16       Impact factor: 7.038

8.  Evaluation of a treatment strategy for optimising preoperative chemoradiotherapy in stage III non-small-cell lung cancer.

Authors:  Erik C J Phernambucq; Femke O B Spoelstra; Marinus A Paul; Suresh Senan; Christian F Melissant; Pieter E Postmus; Egbert F Smit
Journal:  Eur J Cardiothorac Surg       Date:  2009-07-17       Impact factor: 4.191

9.  Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.

Authors:  Hideo Kunitoh; Harubumi Kato; Masahiro Tsuboi; Taro Shibata; Hisao Asamura; Yukito Ichinose; Yukito Ichonose; Nobuyuki Katakami; Kanji Nagai; Tetsuya Mitsudomi; Akihide Matsumura; Ken Nakagawa; Hirohito Tada; Nagahiro Saijo
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

10.  Potential of reduction in total tumor volume measured with 3D-MRI as a prognostic factor for locally-advanced breast cancer patients treated with primary chemotherapy.

Authors:  Kenji Akazawa; Yasuhiro Tamaki; Tetsuya Taguchi; Yoshio Tanji; Yasuo Miyoshi; Seung Jim Kim; Kenzo Shimazu; Satsuki Ueda; Tetsu Yanagisawa; Noritsugu Okishiro; Mitsunobu Imazato; Kozuma Yasuyuki; Yoshinobu Sato; Shinichi Tamura; Shinzaburo Noguchi
Journal:  Breast J       Date:  2008-10-13       Impact factor: 2.431

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.